On May 29, the "Create the Future" 2026 Entrepreneurship Competition (Heilongjiang Provincial Selection Event and the 4th Qiqihar "Hechuang Cup" Innovation and Entrepreneurship Competition) was held in Qiqihar. This year's competition was jointly organized by multiple departments of Qiqihar City. Heilongjiang UnicornShell Pharmaceutical Technology Co., Ltd. participated with its "Keshan Plant-Based Capsule Industrialization Project." Leveraging its technical accumulation and industrialization foundation in the field of plant-based pharmaceutical excipients, the company won the second prize (second place) in the municipal competition and successfully advanced to the provincial competition.

UnicornShell is a technology-driven enterprise specializing in the R&D, production, and sales of plant-based pharmaceutical excipients and innovative traditional Chinese medicine (TCM) preparations, dedicated to promoting medication safety and human health development through plant-based materials.

This competition focused on innovation, entrepreneurship, and achievement commercialization, promoting high-quality projects to accelerate their implementation and industrial development. UnicornShell's project centered on the application pathways and industrialization directions of plant-based materials in the field of pharmaceutical excipients, clearly demonstrating its technical solutions and application scenarios, which were recognized by the review experts. Winning the award and advancing to the provincial competition is not only a phased recognition of the project's innovation value and development direction, but also reflects UnicornShell's continuous efforts in R&D and achievement commercialization in the plant-based materials field.

In the future, UnicornShell will take this competition as an opportunity to continuously promote technological innovation and application expansion in the field of plant-based pharmaceutical excipients, accelerate the industrialization process, further enhance the project's overall competitiveness, provide support for the development of the regional biomedicine industry, and contribute more growth momentum to Heilongjiang's biomedical economy.